-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-126-section-2-technical-specs.pdf
June 02, 2025 - Use of Multiple Concurrent Antipsychotics in Children Section 2, Technical Specifications
National Collaborative for Innovation in Quality Measurement
Use of Multiple Concurrent Antipsychotics in Children
Administrative Specification
Measure Description
The percentage of children 0 to 20 years of a…
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-216-section-2-tech-specs.pdf
June 02, 2025 - Sickle Cell Disease Technical Specifications
Sickle Cell Disease
Measure 15: Appropriate Emergency Department Fever Management
for Children with Sickle Cell Disease
Description
The percentage of children identified as having Sickle Cell Disease presenting to an emergency
department with fever during the me…
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-166-fecc-table-6.pdf
June 02, 2025 - Section 6, Table 6 Construct Measurement Reliability Testing
Table 6: Construct measurement reliability testing for multi-part indicators
Number
of items
Average
inter-item
polychoric
correlation
Polychoric
Ordinal
Alp…
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/chronic/chipra-177-section-2-technical-specs.pdf
May 23, 2014 - National Collaborative for Innovation in Quality Measurement
National Collaborative for Innovation in Quality Measurement
Administrative Sp…
-
www.ahrq.gov/pqmp/implementation-qi/lessons.html
August 01, 2021 - established following enactment of the Children's Health Insurance Program Reauthorization Act of 2009 (CHIPRA
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-232-section-7-table-10.pdf
June 02, 2025 - Section 7, Table 10
Table 10. Race/Ethnicity by Site for Children (Ages 0-18 years) with Sepsis Syndrome
Race/Ethnicity (%) Hospital 1
(n = 100)
Hospital 2
(n = 100)
Hospital 3
(n = 100)
White
Non-Hispanic
Hispanic
Unknown
Total
-
-
63
63
-
-
59
59
27
5
-
32
Black
Non-Hispanic …
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-229-section-5-table-3.pdf
August 01, 2014 - Section 5, Table 3
Table 3: Evidence for Obtaining a Blood Culture for Treatment of Children with Sepsis Syndrome
Type of
Evidence
Key Findings Level of
Evidence
(USPSTF
Ranking*)
Citations
Clinical
guidelines
Pediatric considerations in severe sepsis: Empiric
antibiotics should be administered with…
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-0231-section-6-table-4.pdf
June 02, 2025 - Table 4. Percent Agreement and Kappa Statistics for Sepsis for Inter-Rater Reliability at Three Study Sites
Table 4: Percent Agreement and Kappa Statistics for Sepsis for Inter-Rater Reliability at Three
Study Sites
Site Eligibility Criteria/
Measure Numerator
Number of
Records
R i d
N Agreed (%) Kappa
St…
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-0231-section-6-table-5.pdf
June 02, 2025 - Table 5
Table 5. Inter-Rater Reliability of Assessment of Event within Specified Time Period
Site Time Total
Records/Times
Abstracted
Percent
Agreement
Kappa
Statistic
Hospital #1 Time of fluid bolus
(within 60 minutes of
diagnosis)
3 100% 1.00
Hospital #2 Time of fluid bolus
(within 60 minutes…
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-232-section-5-table-6.pdf
January 01, 2013 - Section 5, Table 6
1
Table 6: Evidence for Timely Fluid Bolus for Treatment of Children with Severe Sepsis or Septic
Shock
Type of
Evidence
Key Findings Level of
Evidence
(USPSTF
Ranking)
Citations
Clinical
guidelines
Pediatric considerations in severe sepsis:
In children, definitions of sepsis are…
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-232-section-6-table-9.pdf
June 02, 2025 - Section 6, Tables 7-9
Table 9: Documentation of Heart Rate for Children with Severe Sepsis or Septic Shock
Site Numerator Denominator Rate
Hospital #1 3 11 27%
Hospital #2 0 2 0%
Hospital #3 0 4 0%
All Sites 3 17 18%
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-228-section-8-table-6.pdf
June 02, 2025 - Section 8, Table 6
Table 6: Reported Pediatric Sepsis Protocols at Hospitals with Emergency Departments in
Michigan and Ohio
Number
Facilities reporting existence of a pediatric sepsis protocol in
their ED
11
Facilities reporting no pediatric sepsis protocol 16
Facilities reporting an electronic version …
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-0230-section-7-table-8.pdf
June 02, 2025 - Section 7, Table 8
Table 8. Race/Ethnicity by Site for Children (Ages 0-18 years) with Sepsis Syndrome
Race/Ethnicity (%) Hospital 1
(n = 100)
Hospital 2
(n = 100)
Hospital 3
(n = 100)
White
Non-Hispanic
Hispanic
Unknown
Total
-
-
63
63
-
-
59
59
27
5
-
32
Black
Non-Hispanic …
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-232-section-3-table-5.pdf
June 02, 2025 - Section 3, Table 5
Table 5. Ranges for Normal Heart Rates, by Age
Threshold (Normal) Ranges Age
Group
Heart Rates (beats/min)
Term newborn 120 to 180
Up to 1 year 120 to 180
Up to 2 years 120 to 160
Up to 7 years 100 to 140
Up to 15 years 90 to 140
(From Brierley et al., 2009)
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-228-section-5-table-3.pdf
August 01, 2014 - Section 5, Table 3
Table 3: Evidence for Having a Protocol to Identify and Treat Children with Sepsis Syndrome in
the Emergency Department
Type of
Evidence
Key Findings Level of
Evidence
(USPSTF
Ranking*)
Citations
Clinical
guidelines
Recommendation: Performance
improvement efforts in severe sepsis
…
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-0231-section-5-table-3.pdf
January 01, 2013 - Table 3. Evidence for Timely Bolus for Treatment of Children with Severe Sepsis of Septic Shock
Table 3: Evidence for Timely Fluid Bolus for Treatment of Children with Severe Sepsis or Septic
Shock
Type of
Evidence
Key Findings Level of
Evidence
(USPSTF
Ranking*)
Citations
Clinical
guidelines
Pe…
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-0230-section-5-table-4.pdf
January 01, 2014 - Table 4. Evidence for Prompt Antimicrobial Therapy for Treatment of Children With Severe Sepsis or Septic Shock
Table 4: Evidence for Prompt Antimicrobial Therapy for Treatment of Children with Severe Sepsis or Septic Shock
Type of
Evidence
Key Findings Level of
Evidence
(USPSTF
Ranking*)
Citations
C…
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-229-section-7a-table-7.pdf
June 02, 2025 - Section 7.A, Table 7
Table 7: Race/Ethnicity by Site for Children (Ages 0 through 18 years) with Sepsis Syndrome
Hospital White Black Asian or Pacific
Islander
Other or Unknown
Non-
Hispanic
Hispanic Unknown Total Non-
Hispanic
Hispanic Unknown Total Non-
Hispanic
Hispanic Unknown Tot…
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-229-section-6b-table-6.pdf
June 02, 2025 - Section 6B, Table 6
Table 6: Timely Blood Culture for Children with Sepsis Syndrome
Site Numerator Denominator Rate
Hospital #1 64 88 73%
Hospital #2 56 94 60%
Hospital #3 71 92 77%
All Sites 191 274 70%
-
www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-0231-section-7-table-7.pdf
June 02, 2025 - Table 7. Race/Ethnicity by Site for Children (ages 0 through 18 years of age) with Septic Syndrome
Table 7: Race/Ethnicity by Site for Children (Ages 0 through 18 years of age) with Sepsis Syndrome
Hospital White Non-
Hispanic
White
Hispanic
White
Unknown
White
Total
Black Non-
Hispanic
Black
His…